Metabolic surgery can cause amelioration, resolution, and possible cure of type 2 diabetes. Bariatric surgery is metabolic surgery. In the future, there will be metabolic surgery operations to treat type 2 diabetes that are not focused on weight loss. These procedures will rely on neurohormonal modulation related to the gut as well as outside the peritoneal cavity. Metabolic procedures are and will always be in flux as surgeons seek the safest and most effective operative modality; there is no enduring gold standard operation. Metabolic bariatric surgery for type 2 diabetes is more than part of the clinical armamentarium, it is an invitation to perform basic research and to achieve fundamental scientific knowledge. And the Lord God caused a deep sleep to fall upon Adam, and he slept; and he took one of his ribs, and closed up the flesh instead thereof, and the rib which the Lord had taken from man, made he a woman.. .. dGenesis 2:21-22 METABOLIC SURGERY In 1978, in the foreword to the book Metabolic Surgery (1), by author H.B. and Richard L. Varco, we defined the discipline of metabolic surgery "as the operative manipulation of a normal organ or organ system to achieve a biological result for a potential health gain." The procedure described in Genesis was an "operative manipulation" under general anesthesia on a "normal organ" to achieve a "biological result"; it was metabolic surgery. As early as 1896, bilateral oophorectomy was used to cause temporary regression of breast cancer metastases (2). The 100-year heyday of peptic, primarily duodenal, ulcer surgery, from the late 19th century to the discovery of Helicobacter pylori, involved operating on normal stomachs and vagus nerves to cure the pathologic lesion, a distal ulcer left untouched by the surgeon. This was metabolic surgery, as was the partial ileal bypass (Fig. 1) for the treatment of hypercholesterolemia, introduced in 1962 and 1963 (3,4). The partial ileal bypass was used as the intervention modality in the Program on the Surgical Control of the Hyperlipidemias (POSCH) (5-8), the first randomized controlled trial to use metabolic surgery. POSCH was the first study definitively to demonstrate the benefits of marked cholesterol lowering in preventing myocardial infarctions, peripheral vascular disease, and the need for coronary artery